Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapy

Journal of Clinical Apheresis

Volumn 22, Issue 1, 2007, Pages 26-30

  Tripodi, Gino ^a   Risso, Marco ^a   Tenerini, Loredana ^a   Gandullia, Paolo ^a   Castellano, Emanuela ^a   Rivabella, Lucia ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Bullous pemphigoid; Extracorporeal photochemotherapy; Inflammatory bowel disease; Pediatrics; Plasma exchange

Indexed keywords

CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; METHOXSALEN; METHYLPREDNISOLONE; TACROLIMUS;

ANAMNESIS; ARTICLE; BULLOUS PEMPHIGOID; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENTERITIS; FEMALE; FLUORESCENCE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MONONUCLEAR CELL; PHOTOCHEMOTHERAPY; PLASMAPHERESIS; PRESCHOOL CHILD; REMISSION; TREATMENT OUTCOME;

CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; PEMPHIGOID, BULLOUS; PHOTOPHERESIS; PLASMA EXCHANGE; REMISSION INDUCTION;

EID: 33947182448     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20115     Document Type: Article

References (29)

1. Khumalo N, Kitschig G, Middleton P, Hollis S, Wojnarowska F, Murrell D. Interventions for bullous pemphigoid. The Cochrane Database of Systematic Reviews 2005; Issue 3. A No.: CD002292. DOI:10.1002/14651858.CD002292.pub2.
2. Mazzi G, Raineri A, Zanolli FA, Da Ponte C, De Roia D, Santarossa L, Guerra R, Orazi BM. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. Transfus Apher Sci 2003;28:13-18.
3. Kitabata Y, Sakurane M, Orita H, Kamimura M, Siizaki K, Narukawa N, Kaketaka A, Abe T, Kobata H, Azikawa T. Double filtration plasmapheresis for the treatment of bullous pemphigoid: a case report. Ther Apheresis 2001;5:484-490.
4. Wollina U, Lange D, Looks A. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous disease. Dermatology 1999;198:140-144.
5. Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB. Inflammatory bowel disease. Arch Dis Child 2006;91:426-432.
6. Sands BE. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories? Gut 2006;55:437-441.
7. Selset Aandahl G, Jacobsen CD, Rode L, Rathe Oedegaard E. Preliminary experience with plasma exchange in patients with ulcerative colitis. Transfus Sci 2000;22:155-160.
8. Fixa B, Komarkova O, Krejsek J, Bures J. Vnitr Lek 1991;37:80-84.
9. Reinisch W, Nahavandi H, Santella R, Zhang Y, Gasche C, Moser G, Waldhor T, Gangl A, Vogelsang H, Knobler R. Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study. Aliment Pharmacol Ther 2001;15:1313-1322.
10. Fisler RE, Saeb M, Liang MG, Howard RM, McKee PH. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol 2003;25:183-189.
11. Roujeau JC, Guillaume JC, Morel P, Crickx B, Dalle E, Doutre MS, Guillot B, Godard W, Gorin I, Labeille B. Plasma exchange in bullous pemphigoid. Lancet 1984;2:486-488.
12. Guillaume JC, Vaillant L, Bernard P, Picard C, Prost C, Labeille B, Guillot B, Foldes-Pauwels C, Prigent F, Joly P. Controlled trial of azathioprine and plasma exchange in addition to prednisolone un the treatment of bullous pemphigoid. Arch Dermatol 1993;129:49-53.
13. Yamada H, Yaguchi H, Takamori K, Ogawa H. Plasmapheresis for the treatment of pemphigus vulgaris and bullous pemphigoid. Ther Apher 1997;1:178-182.
14. Egan CA, Meadows KP, Zone JJ. Plasmapheresis as a steroid saving procedure in bullous pemphigoid. Int J Dermatol 2000;39: 320-325.
15. Roujeau JC, Revuz J, Touraine R, Joneau-Fabre M, Mannoni P. Cortico-resistant bullous pemphigoid. Favorable results with plasmapheresis. Nouv Presse Med 1979;8:3362.
16. Ogawa Y, Adachi A, Okamoto M, Hashimoto T, Tomita Y. A case of refractory bullous pemphigoid with plasmapheresis-associated thrombocitopenia: efficacy of pulsed intravenous cyclophosphamide therapy. J Dermatol 2004;31:651-654.
17. Lee MW, Lee WS, Choi JH, Sung KJ, Moon KC, Koh JK. A case of severe bullous pemphigoid treated with plasmapheresis. J Dermatol Treat 2001;12:59-60.
18. Bossuyt X. Serologic markers in inflammatory bowel disease. Clinical Chem 2006;52:171-181.
19. Carter MJ, Lobo AJ, Travis SP. IBD Section, British Society of gastroenterology. Gut 2004;53S:V1-V16.
20. Escher JC, Taminiau JA, Nieuwenhuis EE, Buller HA, Grand RJ. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm Bowel Dis. 2003;9:34-58.
21. Bremner AR, Beattie RM. Therapy of Crohn's disease in chilhood. Expert Opin Pharmacother 2002;3:809-825.
22. Bremner AR, Griffiths DM, Beattie RM. Therapy of ulcerative colitis in childhood. Expert Opin Pharmacother 2004;5:37-53.
23. Holdstock GE, Fisher JA, Hamblin TJ, Loehry C. Plasmapheresis in Crohn's disease. Digestion 1979;19:197-201.
24. Danese S, Semeraro S, Papa A, Italia R, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005;11:7227-7236.
25. Nowicki MJ, Bishop PR, Parker PH. Bullous pemphigoid complicating Crohn's disease in a child. Clin Pediatr (Phila). 2002;41: 59-62.
26. Marshall SR. Technology insight: ECP for the treatment of GvHD-can we offer selective immune control without generalized immunosuppression? Nat Clin Pract Oncol 2006;3302-3314.
27. Lanioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A, Cenci F, Bottazzo GF, Carsetti R. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005;79:846-850.
28. Manz RA, Arce S, Cassese G, Hauser AH, Hiepe F, Radbruch A. Humoral immunity and long-lived plasma cell. Curr Opin Immunol 2002;14:517-521.
29. Hoyer BF, Manz RA, Radbruch A, Hiepe F. Long-lived plasma cells and their contribution to autoimmunity. Ann NY Acad Sci 2005;1050:124-133.